Last reviewed · How we verify
Clenpiq
At a glance
| Generic name | Clenpiq |
|---|---|
| Also known as | sodium picosulfate, magnesium oxide, anhydrous citric acid |
| Sponsor | The Cleveland Clinic |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (PHASE1, PHASE2)
- Effects and Tolerability With Clenpiq and Low Residue Diet (NA)
- Comparison of Clenpiq vs Golytely Bowel Preparation (PHASE4)
- A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy (PHASE3)
- Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clenpiq CI brief — competitive landscape report
- Clenpiq updates RSS · CI watch RSS
- The Cleveland Clinic portfolio CI